Literature DB >> 18406283

Endocrine, paracrine and cellular regulation of postnatal anti-müllerian hormone secretion by sertoli cells.

R Rey1.   

Abstract

Anti-Müllerian hormone (AMH) is produced by Sertoli cells from early foetal life to puberty, when it is downregulated by the synergistic action of intratesticular testosterone and meiotic germ cells. During foetal and neonatal life, testosterone is incapable of inhibiting AMH, owing to the lack of androgen receptor expression in Sertoli cells. In the absence of an androgen inhibitory effect, follicle-stimulating hormone increases testicular AMH output.

Entities:  

Year:  1998        PMID: 18406283     DOI: 10.1016/s1043-2760(98)00069-1

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  13 in total

1.  Disorders of sex development: diagnostic approaches and management options-an islamic perspective.

Authors:  Nasir Am Al Jurayyan
Journal:  Malays J Med Sci       Date:  2011-07

Review 2.  Evaluation of testicular function in prepubertal children.

Authors:  Rosita A Condorelli; Rossella Cannarella; Aldo E Calogero; Sandro La Vignera
Journal:  Endocrine       Date:  2018-07-07       Impact factor: 3.633

3.  Assessment of Leydig and Sertoli cell functions in infants with nonmosaic Klinefelter syndrome: insulin-like peptide 3 levels are normal and positively correlated with LH levels.

Authors:  Sylvie Cabrol; Judith L Ross; Ilene Fennoy; Claire Bouvattier; Marc Roger; Najiba Lahlou
Journal:  J Clin Endocrinol Metab       Date:  2011-02-09       Impact factor: 5.958

4.  Altered testicular development as a consequence of increase number of sertoli cell in male lambs exposed prenatally to excess testosterone.

Authors:  Pedro P Rojas-García; Mónica P Recabarren; Teresa Sir-Petermann; Rodolfo Rey; Sergio Palma; Albert Carrasco; Carlos C Perez-Marin; Vasantha Padmanabhan; Sergio E Recabarren
Journal:  Endocrine       Date:  2012-10-18       Impact factor: 3.633

5.  Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.

Authors:  Mara Y Roth; Kat Lin; Katrine Bay; John K Amory; Bradley D Anawalt; Alvin M Matsumoto; Brett T Marck; William J Bremner; Stephanie T Page
Journal:  Fertil Steril       Date:  2012-10-03       Impact factor: 7.329

Review 6.  Anti-müllerian hormone: a valuable addition to the toolbox of the pediatric endocrinologist.

Authors:  Nathalie Josso; Rodolfo A Rey; Jean-Yves Picard
Journal:  Int J Endocrinol       Date:  2013-12-08       Impact factor: 3.257

Review 7.  Anti-Müllerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis.

Authors:  Nadia Y Edelsztein; Romina P Grinspon; Helena F Schteingart; Rodolfo A Rey
Journal:  Int J Pediatr Endocrinol       Date:  2016-10-28

8.  Adverse pathophysiological influence of early testosterone therapy on the testes of boys with higher grade sex chromosome aneuploidies (HGAs): a retrospective, cross-sectional study.

Authors:  M Spaziani; C Tarantino; C Pozza; A Anzuini; F Panimolle; G Papi; D Gianfrilli; A Lenzi; A F Radicioni
Journal:  J Endocrinol Invest       Date:  2020-10-24       Impact factor: 4.256

Review 9.  Anti-müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development.

Authors:  Marie Lindhardt Johansen; Casper P Hagen; Trine Holm Johannsen; Katharina M Main; Jean-Yves Picard; Anne Jørgensen; Ewa Rajpert-De Meyts; Anders Juul
Journal:  Int J Endocrinol       Date:  2013-12-03       Impact factor: 3.257

10.  Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue.

Authors:  Romina P Grinspon; Luz Andreone; Patricia Bedecarrás; María Gabriela Ropelato; Rodolfo A Rey; Stella M Campo; Ignacio Bergadá
Journal:  Int J Endocrinol       Date:  2013-11-12       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.